Title: Adult Congenital Heart Disease: 2025 Guidelines and Clinical Implications Introduction As the landscape of adult congenital heart disease (ACHD) continues to evolve, the 2025 guidelines provide critical updates that shape our approach to diagnosis, management, and long-term care. This presentation aims to highlight the key recommendations from the guidelines and their clinical implications for healthcare providers. Overview of Adult Congenital Heart Disease • Definition and prevalence of ACHD evolution of ACHD and when was the specialty first introduced Evolution of ACHD guidelines since the first guidelines in 2008, then 2018, and then 2025 • Importance of lifelong care for patients with congenital heart defects • Transitioning from pediatric to adult care Key Updates in the 2025 Guidelines 1. Risk Stratification and Assessment • Emphasis on comprehensive evaluation of ACHD patients • Use of advanced imaging techniques for better assessment • Importance of individualized risk stratification 2. Management of Comorbidities • Addressing common comorbidities such as pulmonary hypertension, arrhythmias, and heart failure • Recommendations for multidisciplinary care teams 3. Pregnancy and Reproductive Health • Updated guidelines on managing pregnancy in women with ACHD • Counseling on risks and monitoring strategies 4. Transition of Care • Best practices for transitioning patients from pediatric to adult care • Importance of continuity in care and patient education 5. Long-term Follow-up and Surveillance • Recommendations for regular follow-up and surveillance protocols • Importance of patient engagement in self-management Clinical Implications • Enhanced patient outcomes through adherence to guidelines • The role of healthcare providers in educating patients about their condition • Importance of collaboration among cardiologists, primary care physicians, and other specialists Limitations and areas of growth for ACHD Team model for ACHD patients Conclusion The 2025 guidelines for adult congenital heart disease represent a significant advancement in our understanding and management of this complex patient population. By implementing these recommendations, we can improve patient care, enhance quality of life, and ensure better long-term outcomes for individuals living with ACHD. Thank you for your attention. I look forward to your questions and discussions on this vital topic.